Drug Profile
JBT 3002
Alternative Names: L 3002Latest Information Update: 24 Aug 2005
Price :
$50
*
At a glance
- Originator Jenner Biotherapies (CEASED)
- Class Antineoplastics
- Mechanism of Action Immunostimulants; Nitric oxide synthase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cancer; Chemotherapy-induced damage